Source: ChildrensHealthDefense.org
Editor’s note: This is the first in a two-part series examining federal funding for behavior modification approaches to increase uptake among teens of the human papillomavirus vaccine.
The U.S. Department of Health and Human Services (HHS) is funding a scientist who also is a paid consultant for Merck to conduct research on how to increase teen uptake of the human papillomavirus (HPV) vaccine, documents obtained by Children’s Health Defense (CHD) via a Freedom of Information Act (FOIA) request revealed.
Merck manufactures Gardasil, the only HPV vaccine available in the U.S.